Disease: diffuse-type gastric cancer (DGC)  
NumberOfSamples: 84 DGC patients  
SamplingTime: within 30 min after operation  
Temperature: −80 °C  
Temperature: −40 °C  
SampleTreatment: formalin fixed and paraffin embedded  
Staining: H&E-stained sections  
AssayName: IHC for MLH1, PMS2, MSH2, and MSH6  
AssayName: protein profiling  
AssayName: DNA sequencing  
AssayName: liquid chromatography tandem mass spectrometry (LC-MS/MS)  
Instrument: Aperio Scanscope (Aperio Technologies Vista, CA, USA)  
Instrument: Orbitrap Fusion  
Instrument: Orbitrap Fusion Lumos  
Instrument: Q Exactive Plus mass spectrometers  
Instrument: Easy-nLC 1000 nanoflow LC system  
Instrument: Q Exactive HF mass spectrometer  
Instrument: UltiMate 3000 RSLCnano System  
Instrument: Illumina HiSeq 2000  
Compound: 8 M Urea  
Compound: 100 mM Tris Hydrochloride  
Compound: acetonitrile  
ConcentrationOfCompound: 10 mM dithiothreitol  
ConcentrationOfCompound: 10 mM iodoacetamide  
ConcentrationOfCompound: 0.1% formic acid  
ReductionReagent: dithiothreitol  
AlkylationReagent: iodoacetamide  
CleavageAgent: trypsin  
NumberOfFractions: six fractions  
FlowRateChromatogram: 600 nl/min  
CollisionEnergy: 27%  
PrecursorMassTolerance: 20 ppm  
FragmentMassTolerance: 50 mmu  
FragmentMassTolerance: 0.5 Da  
NumberOfMissedCleavages: two missed cleavages  
Modification: cysteine carbamidomethylation  
Modification: N-acetylation  
Modification: oxidation of methionine  
CellLine: 293T cell lysate  
Time: 30 min  
Time: additional 30 min  
Time: every 2 days  
Temperature: 56 °C  
Temperature: room temperature